Osteogenic Enrichment of Adipose Derived Stromal Cells
脂肪源性基质细胞的成骨富集
基本信息
- 批准号:8723642
- 负责人:
- 金额:$ 39.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-03 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdipose tissueAdultAgeBioinformaticsBiomedical EngineeringBone MarrowBone TissueCaliberCalvariaCase StudyCell SeparationCell Surface ReceptorsCell surfaceCellsCellular biologyCephalicChildClinical ResearchClinical TrialsComplementary DNAComplexComputer AnalysisDataDefectDevelopmental BiologyDiseaseEffectivenessEtiologyFutureGene ExpressionGene Expression ProfileGene TargetingGenesGenetic TranscriptionGrowthHarvestHealedHeterogeneityHumanIn VitroIncidenceIndividualInfectionInjuryLaboratoriesLifeMesenchymalMethodsMicrofluidicsMolecular ProfilingMusMusculoskeletal SystemOperative Surgical ProceduresOrganogenesisOsteogenesisParietal bone structurePatientsPilot ProjectsPopulationPopulation HeterogeneityProceduresReactionReagentRegenerative MedicineResolutionReverse Transcriptase Polymerase Chain ReactionRiskScienceStem cellsStromal CellsSubgroupSuction LipectomySurface AntigensSurgeonTechniquesTherapeuticTissue EngineeringTissuesbaseboneclinical applicationcostcraniofacialcraniumhealingimmature animalimprovedin vivoinnovationinterestmandible/maxillamature animalnovelosteogenicosteoprogenitor cellprospectivepublic health relevancereconstructionregenerativerepairedresponsescaffoldskeletalskeletal regenerationstemstem cell biologytissue regenerationtissue repair
项目摘要
DESCRIPTION (provided by applicant): Multiple lines of evidence suggest that human adipose-derived stromal cells (hASCs) hold promise for future use in craniofacial skeletal regeneration. Human ASCs are easily harvested by simple liposuction procedures and are readily expandable as compared to bone marrow mesenchymal cells. Moreover, human ASCs undergo rapid osteogenic differentiation. In our laboratory, we have observed convincingly that ASCs, whether derived from mouse or human origin, contribute to osseous healing of mouse calvarial defects. For example, a surgical defect in the mouse parietal bone (4mm in diameter) shows no healing when untreated even up to 16 weeks post injury. Upon direct hASC application with an osteoconductive scaffold, significant bony healing is observed in as little as 4 weeks post injury. Perhaps most exciting are those applications of hASCs to the human patient. In small pilot studies, defects of the cranium, maxilla, and mandible have been either healed or enabled to heal faster with the use of hASCs. The current understanding of ASC identity and function, however, remains insufficient to allow larger clinical trials and applications as they are a highly heterogeneous population of cells. While surface antigen expression is an important component to this understanding, it is likely that more in depth analysis will be required to fully characterize hASCs. We aim to provide this analysis through completion of the Specific Aims described in this proposal. We expect the results of these studies to move the field forward by providing a new understanding of the transcriptional diversity within hASCs. We anticipate that the findings from our innovative approach will help to define the relationship between transcriptional activity and cell surface markers on a single cell level. This understanding will allow us to more specifically enrich for a population of cells ideal for craniofacial skeletal regeneration.
描述(由申请人提供):多条证据表明,人脂肪源性基质细胞(hASC)有望在未来用于颅面骨骼再生。人ASC容易通过简单的吸脂程序收获,并且与骨髓间充质细胞相比易于扩增。此外,人ASC经历快速成骨分化。在我们的实验室中,我们已经令人信服地观察到,ASCs,无论是来自小鼠还是人的起源,有助于小鼠颅骨缺损的骨愈合。例如,小鼠顶骨中的手术缺损(直径为4 mm)在未治疗时甚至在损伤后长达16周时也没有愈合。在直接hASC与骨传导支架一起应用时,在损伤后短至4周内观察到显著的骨愈合。也许最令人兴奋的是hASC在人类患者中的应用。在小型试点研究中,颅骨、上颌骨和下颌骨的缺陷已经愈合或能够通过使用hASC更快地愈合。然而,目前对ASC身份和功能的理解仍然不足以允许更大的临床试验和应用,因为它们是高度异质的细胞群体。虽然表面抗原表达是这一理解的重要组成部分,但可能需要更深入的分析来充分表征hASC。我们的目标是通过完成本提案中描述的具体目标来提供这种分析。我们期望这些研究的结果通过提供对hASC内转录多样性的新理解来推动该领域的发展。我们预计,我们的创新方法的发现将有助于在单细胞水平上定义转录活性和细胞表面标志物之间的关系。这一理解将使我们能够更具体地富集颅面骨骼再生的理想细胞群。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GEOFFREY C GURTNER其他文献
GEOFFREY C GURTNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GEOFFREY C GURTNER', 18)}}的其他基金
TARGETING HIF-1α DYSFUNCTION TO TREAT PRESSURE ULCERS IN THE AGED
针对 HIF-1α 功能障碍治疗老年人压疮
- 批准号:
10685482 - 财政年份:2022
- 资助金额:
$ 39.49万 - 项目类别:
TARGETING HIF-1α DYSFUNCTION TO TREAT PRESSURE ULCERS IN THE AGED
针对 HIF-1α 功能障碍治疗老年人压疮
- 批准号:
10444745 - 财政年份:2022
- 资助金额:
$ 39.49万 - 项目类别:
Diabetic Foot Ulcer Biofilm Infection and Recurrence
糖尿病足溃疡生物膜感染和复发
- 批准号:
10947670 - 财政年份:2020
- 资助金额:
$ 39.49万 - 项目类别:
Diabetic Foot Ulcer Biofilm Infection and Recurrence
糖尿病足溃疡生物膜感染和复发
- 批准号:
10417228 - 财政年份:2020
- 资助金额:
$ 39.49万 - 项目类别:
Diabetic Foot Ulcer Biofilm Infection and Recurrence
糖尿病足溃疡生物膜感染和复发
- 批准号:
10256045 - 财政年份:2020
- 资助金额:
$ 39.49万 - 项目类别:
Diabetic Foot Ulcer Biofilm Infection and Recurrence
糖尿病足溃疡生物膜感染和复发
- 批准号:
10044343 - 财政年份:2020
- 资助金额:
$ 39.49万 - 项目类别:
Diabetic Foot Ulcer Biofilm Infection and Recurrence
糖尿病足溃疡生物膜感染和复发
- 批准号:
10376509 - 财政年份:2020
- 资助金额:
$ 39.49万 - 项目类别:
Stanford Advanced Wound Care Center Clinical Research Unit
斯坦福高级伤口护理中心临床研究部
- 批准号:
10203948 - 财政年份:2018
- 资助金额:
$ 39.49万 - 项目类别:
Stanford Advanced Wound Care Center Clinical Research Unit
斯坦福高级伤口护理中心临床研究部
- 批准号:
10230438 - 财政年份:2018
- 资助金额:
$ 39.49万 - 项目类别:
Stanford Advanced Wound Care Center Clinical Research Unit
斯坦福高级伤口护理中心临床研究部
- 批准号:
10377776 - 财政年份:2018
- 资助金额:
$ 39.49万 - 项目类别:
相似海外基金
Deciphering the role of adipose tissue in common metabolic disease via adipose tissue proteomics
通过脂肪组织蛋白质组学解读脂肪组织在常见代谢疾病中的作用
- 批准号:
MR/Y013891/1 - 财政年份:2024
- 资助金额:
$ 39.49万 - 项目类别:
Research Grant
ESTABLISHING THE ROLE OF ADIPOSE TISSUE INFLAMMATION IN THE REGULATION OF MUSCLE MASS IN OLDER PEOPLE
确定脂肪组织炎症在老年人肌肉质量调节中的作用
- 批准号:
BB/Y006542/1 - 财政年份:2024
- 资助金额:
$ 39.49万 - 项目类别:
Research Grant
Canadian Alliance of Healthy Hearts and Minds: Dissecting the Pathways Linking Ectopic Adipose Tissue to Cognitive Dysfunction
加拿大健康心灵联盟:剖析异位脂肪组织与认知功能障碍之间的联系途径
- 批准号:
479570 - 财政年份:2023
- 资助金额:
$ 39.49万 - 项目类别:
Operating Grants
Determinants of Longitudinal Progression of Adipose Tissue Inflammation in Individuals at High-Risk for Type 2 Diabetes: Novel Insights from Metabolomic Profiling
2 型糖尿病高危个体脂肪组织炎症纵向进展的决定因素:代谢组学分析的新见解
- 批准号:
488898 - 财政年份:2023
- 资助金额:
$ 39.49万 - 项目类别:
Operating Grants
Activation of human brown adipose tissue using food ingredients that enhance the bioavailability of nitric oxide
使用增强一氧化氮生物利用度的食品成分激活人体棕色脂肪组织
- 批准号:
23H03323 - 财政年份:2023
- 资助金额:
$ 39.49万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of new lung regeneration therapies by elucidating the lung regeneration mechanism of adipose tissue-derived stem cells
通过阐明脂肪组织干细胞的肺再生机制开发新的肺再生疗法
- 批准号:
23K08293 - 财政年份:2023
- 资助金额:
$ 39.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A study on the role of brown adipose tissue in the development and maintenance of skeletal muscles
棕色脂肪组织在骨骼肌发育和维持中作用的研究
- 批准号:
23K19922 - 财政年份:2023
- 资助金额:
$ 39.49万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Adipose Tissue T Cell Polarization and Metabolic Health in Persons Living with HIV
HIV 感染者的脂肪组织 T 细胞极化和代谢健康
- 批准号:
10619176 - 财政年份:2023
- 资助金额:
$ 39.49万 - 项目类别:
Estrogen Signaling in the Ventromedial Hypothalamus Modulates Adipose Tissue Metabolic Adaptation
下丘脑腹内侧区的雌激素信号调节脂肪组织代谢适应
- 批准号:
10604611 - 财政年份:2023
- 资助金额:
$ 39.49万 - 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
- 批准号:
10813753 - 财政年份:2023
- 资助金额:
$ 39.49万 - 项目类别: